Cancer Information

VIDEOS

Stage II III NSCLC Adjuvant Afatinib Trial Ended Early, What Did We Learn About Adjuvant Targeted Therapy

We are excited to share with you a recent series of discussions between Drs. Howard (Jack) West, MD, Associate Clinical Professor, Medical Oncology...

Stage I NSCLC, Retrospective Japanese Data and the Threshold for Recommending Adjuvant Chemo

We are excited to share with you a recent series of discussions between Drs. Howard (Jack) West, MD, Associate Clinical Professor, Medical Oncology...

GRACE & Living Yoga Therapy Present: Managing Fatigue & Building Gentle Strength with Bed-Bound Therapeutic Yoga

GRACE is excited to bring to you more in our new series on surviving with cancer GRACE is excited to bring to you more in our series on surviving with...

GRACE & Living Yoga Therapy Present: Relieving Constipation Through Therapeutic Yoga

GRACE is excited to bring to you more in our new series on surviving with cancer GRACE is excited to bring to you more in our series on surviving with...

GRACE & Living Yoga Therapy Present: Managing Fatigue, Building Strength, and Creating Balance in the Hospital

GRACE is excited to bring to you more in our new series on surviving with cancer GRACE is excited to bring to you more in our series on surviving with...

ARTICLES

The Empowered Patient - Knowledge is Power when Combating Cancer

With the plethora of Medicare options available, here is an overview of Medicare terms and options along with things to consider when choosing a...

Options for Managing Recurrent Pleural Effusions
From the Grace Archives | Originally Published March 18, 2007 | By Dr. West Between 7 and 15% of patients with lung cancer develop a malignant pleural...
Options for Managing Recurrent Pleural Effusions
From the Grace Archives | Originally Published March 18, 2007 | By Dr. West Between 7 and 15% of patients with lung cancer develop a malignant pleural...
Part 1: Lung Cancer Isn’t Your Fault, Even If You Smoked
From the Grace Archives | Originally Published November 12, 2014 | By Dr. Weiss | Leave a comment Smoking is the most common cause of lung cancer; 85%...
Part 1: Lung Cancer Isn’t Your Fault, Even If You Smoked
From the Grace Archives | Originally Published November 12, 2014 | By Dr. Weiss | Leave a comment Smoking is the most common cause of lung cancer; 85%...

ONLINE COMMUNITY

2020 TTF AM SESSION Q&A Panel - The Role of Liquid Biopsies
In this video from the AM Question and Answer Session of the event, Drs. West, Raez, Weiss and Janne discuss the role of liquid biopsies to track...
ASCO/ESMO 2020 Debio 1143/ Xevinapant Study Update
Here's another end of year review of new data. Watch out, it's hopeful! "Debio/ Xevinapant Study Update What Have We Learned About Debio 1143...
ASCO/ESMO 2020 - KEYNOTE 048 Study Update, What Have We Learned?
Here's a new head and neck cancer video. Not only can't I say enough about how much I appreciate learning about new findings but they speak about the...
Rozlytrek-
Hello. My mom (aged 79, Stage 4, NSCLC, diagnosed 1/2014, currently on Rozlytrek) had a “Chest CT with Contrast” this week. Is it appropriate for the...
Embryonic adenocarcinoma
I know that I have adenocarcinoma but doctor said also embryonic type. Can anyone explain what it is and does targeted meds for efgr mutation work on...

Recent Comments

Multiple EGFR mutation lung cancer
Unfortunately, there isn't…
Comment By JanineT GRACE … on Aug 13, 2025 9:22 am
worried about lung cancer
Hi Peter,I'm sorry you're…
Comment By JanineT GRACE … on Oct 25, 2023 11:26 am
Multiple EGFR mutation lung cancer
Chemo and Immuno
Comment By JanineT GRACE … on Aug 13, 2025 9:22 am
Progression on Tagrisso (Osimertinib)
Hi Chen, I'm sorry to hear…
Comment By JanineT GRACE … on Jan 29, 2025 10:22 am

ASCO 2018 Roundtable - Lung Cancer - Keynote189 - Cisplatin or Carboplatin with Alimta & Keytruda - Is this a Practice Changing Approach?

Video

Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate Director for Clinical Research at UC Davis Comprehensive Cancer Center, and Sandip Patel - Medical Oncologist and Associate Professor of Medicine at Moores Cancer Center, UC San Diego Health, gathered post meeting to discuss new information from ASCO 2018 regarding lung cancer.  

Local therapies for metastatic NSCLC while on Osmirtinib

Discussion Topic
Stage IV NSCLC

Hi. I listened to a panel discussion on Saturday Nov 10, led by Dr Jack West, on local therapies for oligo-progression or oligo-metastatic disease when a systemic therapy like Tagrisso is on place and working. The panel talked about radiation and surgery options. They did not mention internal radiation treatments like SIRT radio-embolization or radio-frequency ablation. 

I am in exactly the position described and I will most likely have one of these procedures on my liver shortly. 

Adrenal metastasis from NSCLC

Discussion Topic
Stage IV NSCLC

Greetings all,

I'm a medical doctor from Vietnam.

I want to discuss to you about my patient. He is 58 years old, he is hospitalize with chronic coughs symptoms. After he was taken chest CT Scaner and biopsy show results Adenocarcinoma. Then he was taken PET/CT scan:

In right lower lobe lung cancer: Size 4cm, Max SUV: 8.

Right adreanl have Max SUV: 7,8

My patient have no EGFR muntation detacted.

I am doing test: ALK, ROS 1, DP L1.

Local Therapies for Metastatic Lung Cancer Who, What, Why, When and How?

Discussion Topic
Stage IV NSCLC

Hi Grace Members,

Grace is happy to present in partnership with the Swedish Cancer Institute " Local Therapies for Metastatic Lung Cancer Who, What, Why, When and How?"  this Saturday, November 10, 2018 | 10:00 am– 1:00 pm Pacific time.   This seminar will be available at no charge in person and as a live webinar.

I joined GRACE as a caregiver for my husband who had a Pancoast tumor, NSCLC stage III in 2009. He had curative chemo/rads then it was believed he had a recurrence in the spine/oligometastasis that was radiated. He's 10 years out from treatment.

ASCO 2018 Roundtable - Lung Cancer - Keynote 042 Trial - Keytruda (Pembrolizumab) as a Single Agent Compared to Doublet Chemotherapy for NSCLC

Video

Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate Director for Clinical Research at UC Davis Comprehensive Cancer Center, and Sandip Patel - Medical Oncologist and Associate Professor of Medicine at Moores Cancer Center, UC San Diego Health, gathered post meeting to discuss new information from ASCO 2018 regarding lung cancer.  

In this roundtable video, the doctors discuss Keytruda (pembrolizumab) as a single agent compared to doublet chemotherapy for NSCLC. 

Lung Cancer Video Library - Chemo Immuno Therapy Combinations in Advanced Squamous NSCLC

Video

Dr. H. Jack West, Medical Director, Thoracic Oncology Program, Swedish Cancer Institute, President and CEO of GRACE offers updates to our Lung Cancer Video Library.

In this video, Dr. West discusses chemotherapy and immunotherapy combinations in advanced squamous non-small cell lung cancer.  

We thank the following organizations for their support  

Lung Cancer Video Library - Does Immunotherapy Work in Patients with Driver Mutations?

Video

Dr. H. Jack West, Medical Director, Thoracic Oncology Program, Swedish Cancer Institute, President and CEO of GRACE offers updates to our Lung Cancer Video Library.

In this video, Dr. West discusses whether immunotherapy works in patients with driver mutations like EGFR and ALK.

We thank the following organizations for their support  

 

Treatment Options From 5 Experts for Newly Diagnosed Follicular Lymphoma: An Online Tool

Article
Did you recently receive a diagnosis of follicular lymphoma?

GRACE has partnered with Clinical Care Options to develop an interactive online tool to help you understand more about your disease and treatment options. Answer a series of multiple-choice questions and then get treatment options chosen by the 5 lymphoma experts listed below.

Subscribe to In Treatment